These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2693400)

  • 1. Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis: correlation with disease.
    Fuchs S; Asher O; Neumann D
    Isr J Med Sci; 1989 Dec; 25(12):690-2. PubMed ID: 2693400
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics of experimental autoimmune myasthenia gravis.
    Christadoss P
    Crit Rev Immunol; 1989; 9(4):247-78. PubMed ID: 2679661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of experimental autoimmune myasthenia gravis in mice. II. Lymphocyte proliferative response to acetylcholine receptor is dependent on Lyt-1+23- cells.
    Christadoss P; Krco CJ; Lennon VA; David CS
    J Immunol; 1981 Apr; 126(4):1646-7. PubMed ID: 7204982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myasthenia gravis and acetylcholine receptor].
    Abramsky O; Aharonov A; Tarrab-Hazdai R; Fuchs S
    Harefuah; 1975 Dec; 89(12):553-6. PubMed ID: 815144
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to acetylcholine receptors as probes of receptor structure and pathological agents in myasthenia gravis.
    Lindstrom J
    Prog Clin Biol Res; 1981; 63():419-28. PubMed ID: 6171828
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis.
    Asher O; Kues WA; Witzemann V; Tzartos SJ; Fuchs S; Souroujon MC
    J Immunol; 1993 Dec; 151(11):6442-50. PubMed ID: 8245477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
    Biesecker G; Koffler D
    J Immunol; 1988 May; 140(10):3406-10. PubMed ID: 3258882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5 gene influences the development of murine myasthenia gravis.
    Christadoss P
    J Immunol; 1988 Apr; 140(8):2589-92. PubMed ID: 3356901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis.
    Giraud M; Eymard B; Tranchant C; Gajdos P; Garchon HJ
    Genes Immun; 2004 Jan; 5(1):80-3. PubMed ID: 14735155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis.
    Asher O; Neumann D; Witzemann V; Fuchs S
    FEBS Lett; 1990 Jul; 267(2):231-5. PubMed ID: 2379584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
    Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
    Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM; Richman DP
    J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis.
    De Baets MH
    Year Immunol; 1989-1990; 6():269-75. PubMed ID: 2701909
    [No Abstract]   [Full Text] [Related]  

  • 16. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte activation in experimental autoimmune myasthenia gravis.
    De Baets MH; Einarson B; Lindstrom JM; Weigle WO
    J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589
    [No Abstract]   [Full Text] [Related]  

  • 18. Adult onset acquired myasthenia gravis in three Great Dane littermates.
    Kent M; Glass EN; Acierno M; Shelton GD
    J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-onset myasthenia gravis.
    Roach ES; Buono G; McLean WT; Weaver RG
    J Pediatr; 1986 Feb; 108(2):193-7. PubMed ID: 3944702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.